138 related articles for article (PubMed ID: 24403510)
1. Characterization of and protection from neurotoxicity induced by oxaliplatin, bortezomib and epothilone-B.
Ceresa C; Avan A; Giovannetti E; Geldof AA; Avan A; Cavaletti G; Peters GJ
Anticancer Res; 2014 Jan; 34(1):517-23. PubMed ID: 24403510
[TBL] [Abstract][Full Text] [Related]
2. Amifostine protects against chemotherapy-induced neurotoxicity: an in vitro investigation.
Verstappen CC; Postma TJ; Geldof AA; Heimans JJ
Anticancer Res; 2004; 24(4):2337-41. PubMed ID: 15330181
[TBL] [Abstract][Full Text] [Related]
3. The pivotal role of intracellular calcium in oxaliplatin-induced inhibition of neurite outgrowth but not cell death in differentiated PC12 cells.
Takeshita M; Banno Y; Nakamura M; Otsuka M; Teramachi H; Tsuchiya T; Itoh Y
Chem Res Toxicol; 2011 Nov; 24(11):1845-52. PubMed ID: 21981408
[TBL] [Abstract][Full Text] [Related]
4. A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicity.
Kobrinsky B; Joseph SO; Muggia F; Liebes L; Beric A; Malankar A; Ivy P; Hochster H
Cancer Chemother Pharmacol; 2013 Nov; 72(5):1073-8. PubMed ID: 24048674
[TBL] [Abstract][Full Text] [Related]
5. In vitro protection from cisplatin-induced neurotoxicity by amifostine and its metabolite WR1065.
Verstappen CC; Geldof AA; Postma TJ; Heimans JJ
J Neurooncol; 1999 Aug; 44(1):1-5. PubMed ID: 10582662
[TBL] [Abstract][Full Text] [Related]
6. [Prophylactic effect of amifostine on oxaliplatin-related neurotoxicity in patients with digestive tract tumors].
Lu P; Fan QX; Wang LX; Wang X; Zong H; Wang RL
Ai Zheng; 2008 Oct; 27(10):1117-20. PubMed ID: 18851795
[TBL] [Abstract][Full Text] [Related]
7. Curcumin reduces cisplatin-induced neurotoxicity in NGF-differentiated PC12 cells.
Mendonça LM; da Silva Machado C; Teixeira CC; de Freitas LA; Bianchi Mde L; Antunes LM
Neurotoxicology; 2013 Jan; 34():205-11. PubMed ID: 23036615
[TBL] [Abstract][Full Text] [Related]
8. CyclinB2 and BIRC5 genes as surrogate biomarkers for neurite outgrowth in SH-SY5Y subclonal cells.
Oe T; Nagashima T; Muramoto M; Yamazaki T; Morikawa N; Okitsu O; Nishimura S; Aoki T; Katayama Y; Kita Y
Neuropharmacology; 2006 Jun; 50(8):1041-7. PubMed ID: 16574167
[TBL] [Abstract][Full Text] [Related]
9. Role of Bcl-xL/Beclin-1 in interplay between apoptosis and autophagy in oxaliplatin and bortezomib-induced cell death.
Kim SY; Song X; Zhang L; Bartlett DL; Lee YJ
Biochem Pharmacol; 2014 Mar; 88(2):178-88. PubMed ID: 24486574
[TBL] [Abstract][Full Text] [Related]
10. Aqueous extract of Lithospermi radix attenuates oxaliplatin-induced neurotoxicity in both in vitro and in vivo models.
Cho ES; Yi JM; Park JS; Lee YJ; Lim CJ; Bang OS; Kim NS
BMC Complement Altern Med; 2016 Oct; 16(1):419. PubMed ID: 27782842
[TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: could it correlate with in vivo neuropathy?
Di Cesare Mannelli L; Zanardelli M; Failli P; Ghelardini C
Free Radic Biol Med; 2013 Aug; 61():143-50. PubMed ID: 23548635
[TBL] [Abstract][Full Text] [Related]
12. Partial Protection of Paclitaxel-induced Neurotoxicity by Antioxidants.
Hara Y; Sakagami H; Shi H; Abe T; Tamura N; Takeshima H; Horie N; Kaneko T; Shiratsuchi H; Kaneko T
In Vivo; 2018; 32(4):745-752. PubMed ID: 29936454
[TBL] [Abstract][Full Text] [Related]
13. Astrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the rat.
Robinson CR; Zhang H; Dougherty PM
Neuroscience; 2014 Aug; 274():308-17. PubMed ID: 24905437
[TBL] [Abstract][Full Text] [Related]
14. Toxic neuropathy.
Umapathi T; Chaudhry V
Curr Opin Neurol; 2005 Oct; 18(5):574-80. PubMed ID: 16155443
[TBL] [Abstract][Full Text] [Related]
15. Experimental epothilone B neurotoxicity: results of in vitro and in vivo studies.
Chiorazzi A; Nicolini G; Canta A; Oggioni N; Rigolio R; Cossa G; Lombardi R; Roglio I; Cervellini I; Lauria G; Melcangi RC; Bianchi R; Crippa D; Cavaletti G
Neurobiol Dis; 2009 Aug; 35(2):270-7. PubMed ID: 19464369
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats.
Meregalli C; Canta A; Carozzi VA; Chiorazzi A; Oggioni N; Gilardini A; Ceresa C; Avezza F; Crippa L; Marmiroli P; Cavaletti G
Eur J Pain; 2010 Apr; 14(4):343-50. PubMed ID: 19695912
[TBL] [Abstract][Full Text] [Related]
17. Treatment with anti-TNF alpha protects against the neuropathy induced by the proteasome inhibitor bortezomib in a mouse model.
Alé A; Bruna J; Morell M; van de Velde H; Monbaliu J; Navarro X; Udina E
Exp Neurol; 2014 Mar; 253():165-73. PubMed ID: 24406455
[TBL] [Abstract][Full Text] [Related]
18. Protection of Bortezomib-induced Neurotoxicity by Antioxidants.
Iijima Y; Bandow K; Amano S; Sano M; Hino S; Kaneko T; Horie N; Sakagami H
Anticancer Res; 2020 Jul; 40(7):3685-3696. PubMed ID: 32620607
[TBL] [Abstract][Full Text] [Related]
19. In vitro cytotoxic effect of proteasome inhibitor bortezomib in combination with purine nucleoside analogues on chronic lymphocytic leukaemia cells.
Duechler M; Linke A; Cebula B; Shehata M; Schwarzmeier JD; Robak T; Smolewski P
Eur J Haematol; 2005 May; 74(5):407-17. PubMed ID: 15813915
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of bradykinin against glutamate neurotoxicity in cultured rat retinal neurons.
Yasuyoshi H; Kashii S; Zhang S; Nishida A; Yamauchi T; Honda Y; Asano Y; Sato S; Akaike A
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2273-8. PubMed ID: 10892873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
